Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
Clinical trial NCT02730455 · COMPLETED
Trial details
- NCT number
- NCT02730455
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-18
- Primary completion
- 2017-11-20
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.